Cancer Immunotherapy: A peptide puzzle
- Johns Hopkins School of Medicine, United States
Cite this article as: eLife 2018;7:e41524
doi: 10.7554/eLife.41524
Figures
Figure 1
Schematic illustration of the anti-cancer immune response.
(a) Gejman et al. found that a cancer that contains a large fraction of immunogenic tumor cells of the same type (shown in green) can be effectively rejected by the immune system of the mouse (left), whereas a cancer that contains a small fraction of immunogenic tumor cells will not be rejected (right). (b) However, a cancer that contains a large fraction of immunogenic tumor cells of different types (shown in different colors) will not be rejected. This behavior observed by Gejman et al. in mice is similar to that seen in humans who do not respond to immunotherapy (McGranahan et al., 2016).
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
